2012

December 11, 2012
BTG plc: Appointment of Non-executive Director

London, UK, 11 December 2012 BTG plc (LSE: BTG), the specialist healthcare company, today announces the appointment of Richard Wohanka as a non-executive director of the Board, effective from 1...

November 20, 2012
BTG plc: Janssen announces that ZYTIGA® has received a positive opinion in the EU for treating chemo-naïve mCRPC patients

London, UK, 20 November 2012 BTG plc (LSE: BTG), the specialist healthcare company, notes the announcement by Janssen-Cilag International NV (Janssen) that the Committee for Medical Products for...

November 19, 2012
Full data from pivotal Phase III trials of Varisolve® PEM presented at the 26th Annual Congress of the American College of Phlebology

London, UK, 19 November 2012 BTG plc (LSE: BTG), the specialist healthcare company, today announces that full data from VANISH-1 and VANISH-2, the two US pivotal Phase III trials of polidocanol...

November 08, 2012
BTG plc: Interim Results

London, UK, 08 November 2012 BTG plc (LSE: BTG), the specialist healthcare company, today announces its interim results for the six months ended 30 September 2012. Click here to down load the PDF

October 03, 2012
BTG plc: Close Period Update

London, UK, 03 October 2012 BTG plc (LSE: BTG), the specialist healthcare company, provides the following update for the six months ended 30 September 2012 ahead of the planned publication of its...

Show 5102550100 per page
Top